# AKLIEF
> **NDA211527** · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2019-10-04
## Drug
- **FDA Application Number:** NDA211527
- **Application type:** New Drug Application
- **Brand name:** AKLIEF
- **Generic name:** TRIFAROTENE
- **Active ingredients:** TRIFAROTENE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** GALDERMA LABS LP
- **Manufacturer:** Galderma Laboratories, L.P.
- **First approval:** 2019-10-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211527)
---
*MORVS · CC0 1.0*